• Skip to content
  • Skip to footer
  • Accessibility options
University of Brighton
  • About us
  • Business and
    employers
  • Alumni and
    supporters
  • For
    students
  • For
    staff
  • Accessibility
    options
Open menu
Home
Home
  • Close
  • Study
    • Courses and subjects
    • Find a course
    • A-Z course list
    • Explore our subjects
    • Academic departments
    • Visiting the university
    • Explore: get to know us
    • Upcoming events
    • Virtual tours
    • Chat to our students and staff
    • Open days
    • Applicant days
    • Order a prospectus
    • Ask a question
    • Studying here
    • Accommodation and locations
    • Applying
    • Undergraduate
    • Postgraduate
    • Transferring from another university
    • The Student Contract
    • Clearing
    • International students
    • Fees and finance
    • Advice and help
    • Advice for students
    • Advice for parents and carers
    • Advice for schools and teachers
    • Managing your application
    • Undergraduate
    • Postgraduate
    • Apprenticeships
  • Research
    • Research and knowledge exchange
    • Research and knowledge exchange organisation
    • The Global Challenges
    • Centres of Research Excellence (COREs)
    • Research Excellence Groups (REGs)
    • Our research database
    • Information for business
    • Community University Partnership Programme (CUPP)
    • Postgraduate research degrees
    • PhD research disciplines and programmes
    • PhD funding opportunities and studentships
    • How to apply for your PhD
    • Research environment
    • Investing in research careers
    • Strategic plan
    • Research concordat
    • News, events, publications and films
    • Research and knowledge exchange news
    • Inaugural lectures
    • Research and knowledge exchange publications and films
    • Academic staff search
  • About us
  • Business and employers
  • Alumni, supporters and giving
  • Current students
  • Staff
  • Accessibility
Search our site
Research-project-banner
Research and knowledge exchange
  • Research organisation
  • Postgraduate research degrees
  • Research features
  • Research environment
  • Groups
    • Groups
    • Applied geosciences
    • Built environment
    • Biomaterials and Drug Delivery
    • Brighton and Sussex Medicines Optimisation
    • Chemistry
    • Stress, ageing and disease
    • Ecosystems and environmental management
    • Education
    • Environment and public health
    • Healthcare Practice and Rehabilitation
    • Interdisciplinary Management and Higher Education
    • Management and Employment
    • Mathematics, Statistics and Operations
    • Musculoskeletal
    • Nuclear physics
    • Past human and environment dynamics
    • Paediatrics
    • Product design
    • Sensory neuroscience
    • Social Science Policy
    • Society space and environment
    • Sport and Exercise Science and Medicine
    • Sport, Tourism and Leisure
    • Sustainability and Resilience Engineering
    • Transforming sexuality and gender
    • Values and sustainability
  • Biomaterials and Drug Delivery
    • Biomaterials and Drug Delivery
    • ENSOR
    • GLIOMA
    • Nanostructured carbon adsorbents for haemoperfusion
    • OncoNanoBBB
    • Rapid and accurate skin cancer detection
    • Surface functionalised nanostructured carbon sorbents
  • GLIOMA

GLIOMA

The research project focuses on the synthesis, characterisation and application of a novel therapeutic nanovaccine (TNVax) that holds multiple modules for targeting glioblastoma multiforme (GBM). The use of TNVax nanoparticles offers a combinatorial approach in killing GBM cells both by immuno- and chemo- therapeutically. Site-specific delivery of the payload will stimulate the host immune system and channel the immune cells to the target site. This approach would enhance the amount of anti-tumour activity offered by multiple means and thereby leaving a strong immune response against GBM based on antigen-antibody interactions. TNVax NPs will be synthesised and characterised using microscopic and spectroscopic techniques and then subjected to in vitro and in vivo evaluations. The pharmacokinetic and pharmacodynamic studies will be carried out and histopathological examinations performed using appropriate murine models induced with GBM cell lines. The potential outcomes of the proposed studies will help patients who suffer from early and advanced GBM by eradicating the disease permanently and leaving good immunological memory.

GLIOMA-image

Schematic representation of glioma therapeutic nanovaccine interaction with cancer cells.

 

Project timeframe and funding

This research project will commence in October 2017 and will end in October 2019.

This project has received funding of EUR 195,455 from the European Union’s Horizon 2020 research and innovation programme through the Marie Skłodowska-Curie Actions initiative. Marie Skłodowska-Curie Actions (MSCA) provide grants for all stages of researchers' careers and encourage transnational, intersectoral and interdisciplinary mobility. The MSCA enable research-focused organisations to host talented foreign researchers and to create strategic partnerships with leading institutions worldwide. Dr Sreejith Raveendran is supported as a Marie Skłodowska-Curie Fellow to complete this project. 

EU-logo

This project has received funding from the Marie Skłodowska-Curie Actions (MSCA) Individual Fellows (IF) under the European Union’s Horizon 2020 research and innovation programme under grant agreement number 749403.

Project aims

TNVax NPs will be synthesised and characterised using microscopic and spectroscopic techniques and then subjected to in vitro and in vivo evaluations. In vitro studies will be performed for drug release kinetics and cytotoxicity using immunofluorescence and FACS analysis. Activation of immune system by TNVax NPs will be evaluated by analysing the amount of immune response induced and production of immune products. The pharmacokinetic and pharmacodynamics studies will be carried out and histopathological examinations performed using appropriate murine models induced with GBM cell lines.

Project findings and impact

This research project is ongoing; output, findings and impact will be updated in due course.

Research team

Dr Irina Savina, Principal Investigator

Dr Sreejith Raveendran, MSCA Individual Fellow 

Output

This research project is ongoing; output will be updated in due course.

Partners

Dr Mo Alavijeh, Pharmidex

Dr Ross Shevchenko, Pharmidex  

Back to top
  • Facebook
  • Twitter
  • Instagram
  • TikTok
  • YouTube
  • LinkedIn icon

Contact us

University of Brighton
Mithras House
Lewes Road
Brighton
BN2 4AT

Main switchboard 01273 600900

Course enquiries

Sign up for updates

University contacts

Report a problem with this page

Quick links Quick links

  • Courses
  • Open days
  • Order a prospectus
  • Academic departments
  • Academic staff
  • Professional services departments
  • Jobs
  • Privacy and cookie policy
  • Accessibility statement
  • Libraries
  • Term dates
  • Maps
  • Graduation
  • Site information
  • Online shop
  • COVID-19

Information for Information for

  • Current students
  • International students
  • Media/press
  • Careers advisers/teachers
  • Parents/carers
  • Business/employers
  • Alumni/supporters
  • Suppliers
  • Local residents